Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

Chimeric: Media Thread, page-613

First 613 Last

Share
Profile

Follow
dalts66

4,365 Posts.

2034

18/02/24

16:23

Post #: 72470413
Share

Originally posted by pinch2020: ↑

The FDA solid tumor bar has been set.

https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor

In a single-arm study, Amtagvi at the now-recommended dosing range shrank tumors in 31.5% of 73 patients who had previously received an anti-PD-1 therapy. After 18.6 months of follow-up, 43.5% of responders had been in remission for more than a year.In a supporting pooled efficacy analysis that included 153 patients, the objective response rate was similar at 31.4%.

Further, 56.3% of responders maintained durable responses at one year. Although not included in the current label, a recent update of the pooled analysis showed that patients lived a median 13.9 months, whereas nearly half of patients were still alive at four years.

Expand

I great to how treatments are progressing. Loo at what has been achieved over the last 10yrs. Great news for patients.

CHM Price at posting: 2.6¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 275 more messages in this thread...

First 613 Last

Add CHM (ASX) to my watchlist